Toll-like receptors (TLRs) are a family of pattern recognition receptors that recognize distinct molecular patterns shared by a broad range of pathogens, including nucleic acids. TLR9, for example, recognizes unmethylated deoxycytidyl-phosphate-deoxyguanosine (CpG) dinucleotides that are common in bacterial and some viral nucleic acids, whereas TLR3 recognizes doublestranded RNA and TLR7/TLR8 recognize single-stranded RNA, which would be found during viral replication. We were interested in whether TLR3, TLR9, and the related TLR9 family members TLR7/TLR8 might play a role in antiviral immune defense at the mucosal epithelial surface of the lower female reproductive tract. We studied cervical epithelial cells and found that they expressed mRNA for TLR3, TLR9, and TLR7, but had only a weak signal for TLR8. For TLR3 and TLR9, protein expression was confirmed to be intracellular. When epithelial cells were incubated with polyinosine-polycytidylic acid and CpG oligodinucleotides, we observed dose-dependent upregulation of interleukin-8 secretion. However, cells failed to respond to a variety of TLR7/TLR8 ligands. Polyinosinepolycytidylic acid also induced production of interferon-beta and chemokine C-C motif ligand 5, whereas CpG DNA did not. Cell activation by synthetic oligodinucleotides occurred only in response to the B class sequences, and required the presence of human-specific CpG motifs. In addition, responses to CpG oligodinucleotides could be inhibited by chloroquine, demonstrating the requirement for endosomal maturation. These data demonstrate that mucosal epithelial cells express functional TLR3 and TLR9, and suggest that these receptors play a role in regulating the proinflammatory cytokine and antiviral environment of the lower female reproductive tract during infection with viral and bacterial pathogens. cervix, immunology, signal transduction
INTRODUCTION
The recognition of invading microorganisms is paramount to the survival of the host, and the innate immune system has evolved as the first line of defense in the immune response. At the mucosal surface, where the host physically interacts with a nonsterile environment, the ability to detect and contain invading pathogens is regularly tested. The lower female reproductive tract is one example of a mucosal environment that is rich in commensal flora while at the same time subject to invasion by a variety of viral, bacterial, and parasitic pathogens. The innate immune defenses at this site include the presence of immunologically active soluble mediators, such as complement and antimicrobial peptides, as well as the physical barrier provided by the polarized epithelium itself. In addition, the epithelial cells at the mucosal surface express several members of the Toll-like receptor (TLR) family, receptors that are central to innate immune defenses ( [1] and reviewed in [1] [2] [3] [4] [5] ).
The human TLR family consists of at least 10 distinct receptors and has been linked to the activation of nuclear factor-kappa B (NFKB) [1, 6] , a transcription factor that is involved in the expression of many proinflammatory cytokines, chemokines, costimulatory proteins, and adhesion molecules. The principal ligands that are recognized by the TLRs are conserved molecular patterns shared by a broad range of pathogens. For instance, TLR4 has been identified as the principal signal transducer in the recognition of lipopolysaccharide [6] [7] [8] , whereas TLR2 confers responsiveness to bacterial lipoproteins and lipopeptides [9] [10] [11] [12] , as well as lipoarabinomannan [13] , lipoteichoic acid [14] , and bacterial porin [15, 16] . Within the TLR family, TLRs 7, 8, and 9 appear to be ''phylogenetic neighbors'' [17] . TLR9 recognizes unmethylated deoxycytidyl-phosphate-deoxyguanosine (CpG) dinucleotides that are common in bacterial and some viral nucleic acids [18, 19] , and there appear to be some interesting species-specific differences between human and mouse TLR9 in terms of the preferred nucleotide recognition sequence [19] . TLR7 and TLR8 were first shown to sense small antiviral compounds known as imidazoquinolines [20, 21] . These guanosine-based antiviral drugs suggested that the natural ligands for TLR7 and TLR8 would be viral nucleic acids, and recently it was reported that mouse TLR7 and human TLR8 (but not human TLR7) could recognize synthetic GU-rich single-stranded RNA (ssRNA) [22, 23] . TLR3 does not appear to be genetically related to the TLR9 family, but shares the ability to recognize nucleic acids, specifically double-stranded RNA (dsRNA) [24] . The expression pattern of TLR3 and the TLR9 family members (which also include TLR7 and TLR8) differs from that of the other TLR family members in that they are expressed within endosomes, and appear to be targeted there by structural features of their cytoplasmic domains [25, 26] .
We were interested in the role TLR3 and TLR9 family members might play in the lower female reproductive tract with regard to the detection of and response to sexually transmitted infections. In this paper we investigate the expression and function of TLR3, TLR9, and TLR7/TLR8 in cervical epithelial cells, specifically examining the ability of these cells to respond to nucleic acid preparations.
MATERIALS AND METHODS

Reagents
PBS and Trypsin-Versene Mixture (trypsin-EDTA) were obtained from Bio-Whittaker. Recombinant human interleukin (IL)1-beta (IL1B), tumor necrosis factor-alpha (TNF), and interferon-gamma (IFNG) were purchased from R&D Systems. Synthetic lipopeptide Pam 3 -Cys-Lip was purchased from EMC Microcollections. The structure of this triacylated lipopeptides is based on the structure of the gonococcal lipoprotein H.8/Lip, and has been described elsewhere [27] 
Cell Culture
The human papillomavirus 16/E6E7 immortalized endocervical (End1/ E6E7), ectocervical (Ect1/E6E7), and vaginal (Vk2/E6E7) epithelial cell lines were a gift from Dr. Raina Fichorova (Brigham and Women's Hospital, Harvard Medical School, Boston, MA) and are described elsewhere [28] . Primary ectocervical epithelial cells (CrEC) derived from tissue donated by a 43-yr-old woman were purchased from Cambrex Bioproducts. Because no identifiable information is available for this sample, it is not considered human subjects research. Cervical epithelial cells were grown in keratinocyte serumfree medium (KSFM; Life Technologies) supplemented with the provided 50 lg/ml bovine pituitary extract, 0.1 ng/ml recombinant epidermal growth factor, and 0.4 mM CaCl 2 (KSFM growth medium). Cells were maintained at 378C in a humidified atmosphere containing 5% CO 2 .
Isolation of Peripheral Blood Mononuclear Cells
Whole blood was obtained from a healthy volunteer using aseptic technique into a heparinized syringe (50 U heparin/ml blood). Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood using Lymphoprep (Axis-Shield) according to the manufacturer's instructions. Cells were washed three times with PBS, resuspended in RPMI 1640 (Gibco/ Invitrogen) supplemented with 10% FBS (Hyclone), and used immediately. All blood draws were collected following informed consent from the donor, with approval from the Institutional Review Board.
RT-PCR Analysis
Total RNA was isolated from cells using the RNeasy kit (Qiagen). Contaminating DNA was removed by treating cells with DNA-free DNase (Ambion). RT and PCR reactions were performed in one step using the OneStep RT-PCR (Invitrogen). The PCR reactions were carried out for 35 cycles at an annealing temperature of 558C in a Perkin Elmer Gene Amp 2400 PCR machine (Perkin Elmer Analytical Instruments). Primer pairs for TLRs 1-10 are listed in Table I . Interferon-beta (IFNB) PCR was carried out using the DualQuantitative RT-PCR Kit according to the manufacturer's instructions (Maxim Biotech).
Antibody Staining and Flow Cytometry
Purified and fluorochrome-conjugated monoclonal antibodies against human TLR3 and TLR9, along with their isotype controls, were purchased from eBioscience. For flow cytometric analysis of protein expression, cells growing in tissue culture were harvested with Trypsin-Versene, and incubated for 30 min on ice with phycoerythrin-conjugated anti-TLR3 or anti-TLR9 antibody, or control IgG, at a concentration of 20 lg/ml diluted in PBS with 1% FBS. For intracellular staining, cells were first treated with Fixation Buffer (4% paraformaldehyde) followed by Permeabilization Buffer (0.1% saponin), according to the manufacturer's protocol (eBioscience). Antibody was diluted in the Permeabilization Buffer with PBS/1% FBS (50:50). After labeling, the cells were washed, resuspended in PBS/1% FBS, and analyzed by flow cytometry using a fluorescence activated cell sorter (FACScan) microfluorimeter (Becton Dickinson). A total of 10 000 events were counted for each condition.
Assays for Chemokine Secretion
Cells were plated in 96-well tissue culture dishes at a density of 5 3 10 4 / well. PBMCs were used immediately, whereas epithelial cells were allowed to rest for 24 h before stimulation. Cells were treated with various stimuli in a reaction volume of 100 ll. After overnight incubation at 378C, the culture supernatants were removed and assayed for interleukin 8 (IL8) and chemokine C-C motif ligand 5 (CCL5; also known as RANTES) using a DuoSet ELISA kit from R&D Systems. Optical density was measured using a Bio-Kinetics microplate reader (Bio-Tek Instruments). All data points were assayed in triplicate, and reported as the mean 6 SD. Significance (P value) was calculated using an unpaired t-test.
RESULTS
Cervical Epithelial Cells Express TLR3 and TLR9
We previously reported that immortalized epithelial cells from the lower female reproductive tract express mRNA for TLR1, TLR2, TLR3, TLR5, and TLR6, but lack mRNA expression of TLR4 and the associated molecule MD2 (also known as LY96) [29] . We confirmed these results and further tested for the remaining TLRs by RT-PCR. As shown in Figure  1 , we found that the immortalized endocervical epithelial cell line, End1/E6E7, expressed mRNA for all 10 human TLRs, with the exception of TLR4 and possibly TLR8, which gave only a weak signal. Similar results were found in the ectocervical and vaginal cell lines (data not shown).
To confirm the PCR result demonstrating expression of TLR3 and TLR9 messenger RNA, we examined the cells for expression of protein using available monoclonal antibodies. Both TLR3 and TLR9 are reported to be localized intracellularly, within endosomes [25, 26, 30] . We initially looked for surface expression of TLR3 and TLR9 by staining live cells and analyzing fluorescence using flow cytometry. As shown in Figure 2 , we found little or no surface expression of either TLR3 (Fig. 2a) or TLR9 (Fig. 2b) by this method. Staining was repeated using cells that had been subjected to fixation and permeabilization as described in Materials and Methods. In this case, we found a significant shift in the cell fluorescence with both the TLR3-and TLR9-specific antibodies, demonstrating that TLR3 and TLR9 expression is primarily intracellular in cervical epithelium. To prove that TLR3 and TLR9 expression was specific for cervical epithelium and not a consequence of the HPV/E6E7 immortalization process, we confirmed the FACS data using primary ectocervical epithelial cells.
Cervical Epithelial Cells Respond to TLR3 and TLR9 Ligands but Not TLR7/TLR8 Ligands
To examine the function of TLR3, TLR9, and the TLR9 family members TLR7 and TLR8 in cervical epithelial cells, we tested the ability of various nucleic acid preparations to upregulate the secretion of IL8. Cells were stimulated with CpG ODN 2006, poly[I:C], and R-848, which have been described as ligands for TLR9, TLR3, and TLR7/TLR8, FIG. 1. Expression of TLRs in cervical epithelial cells. RNA was prepared from End1/E6E7 and assayed by RT-PCR for expression of TLRs 1-10 as described in the text and in Table 1 . Similar results were found for Ect1/ E6E7 and Vk2/E6E7 (data not shown).
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respectively. As a control, we used the TLR2 ligand Pam 3 -CysLip, which we have previously reported to be a potent activator of this cell line [27, 29] . As shown in Figure 3a , we found dose-dependent upregulation of IL8 secretion over baseline in response to both poly[I:C] and CpG, as well as the control lipopeptide Pam 3 Cys-Lip. In contrast, the cells failed to respond to R-848 at the doses tested, although PBMCs stimulated in parallel were strongly activated (data not shown). We further tested the ability of the End1/E6E7 cell line to respond to TLR7/TLR8 ligands by examining a broader dose range of R-848 (1-10 lg/ml) as well as the single stranded RNA preparations ssPolyU and ssRNA40 (1-7.5 lg/ml). However, these ligands, at these doses, also failed to activate the cells to secrete IL8 (data not shown).
To show that the response to nucleic acids was not an artifact of the HPV/E6E7 immortalization process, primary cervical epithelial cells were tested for their responsiveness to the TLR3, TLR9, and TLR7/8 ligands. As we found for the cell line, the primary cells responded to the CpG ODNs and the poly[I:C] with an increase in IL8 secretion over baseline, 
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whereas they remained unresponsive to the R-848 (Fig. 3b) . It is interesting to note that, in comparison to the immortalized cell line, the primary cells had a much higher basal secretion of IL8 while maintaining a 5-to 10-fold increase in cytokine production in response to the stimuli tested. Finally, we wanted to examine the induction of IFN-related signals in response to the nucleic acid preparations. First we examined the upregulation of IFNB in the End1/E6E7 cell line by RT-PCR. As shown in Figure 4 , poly[I:C] upregulated IFNB whereas CpG did not. In addition, we examined upregulation of the chemokine CCL5 in response to these TLR ligands. Although the immortalized epithelial cells failed to secrete CCL5 in response to any stimuli, the primary cells did secrete CCL5 in response to poly[I:C] but not CpG (Fig. 5) .
Cervical Epithelial Cells Respond to B Class but Not A Class CpG ODN
Based on the structure and the types of immune responses induced, ODNs can be classified as type A (also known as type D) or type B (also known as type K). Type A ODNs have chimeric backbones with a core phosphodiester (PO) link between the CpG, which is flanked by phosphorothioate-linked sequences. These ODNs are very potent inducers of IFNA from plasmacytoid dendritic cells and IFNG from NK cells, but have little or no effect on B cells. Type B ODNs have a complete PO backbone, and have a variety of B cell effects, including proliferation, IL6 secretion, and upregulation of activation markers, but they have no effect on IFNA and IFNG (reviewed in [31] ).
To further examine the responses of cervical epithelial cells to the nucleic acid preparations, we compared the activity of ODN 2006 (a B class ODN) or 2336 (an A class ODN) , and assayed for the upregulation of IL8 secretion. As shown in Figure 6 , cells responded only to ODN 2006, the B class ODN. One interesting aspect of TLR9 signaling is that there appear to be some interesting species-specific differences between human TLR9 and mouse TLR9 in terms of the preferred nucleotide recognition sequence [19] . We tested the species specificity of the response in our epithelial cells by stimulating with ODN 1826, a mouse-specific B class ODN, and found that cells were not significantly activated by the mouse sequence in comparison to the human-specific sequence.
TLR9-Mediated Responses in Cervical Epithelium Require Endosomal Acidification
TLR9-dependent responses to CpG ODN and bacterial DNA can be blocked by inhibitors of endosomal acidification or maturation, such as bafilomycin A and chloroquine [32] [33] [34] , a feature that distinguishes TLR9 signaling from that of other TLRs. To further evaluate the role of TLR9 in mediating the response of cervical epithelial cells to oligodinucleotides, we examined the effect of chloroquine on the ability of CpG ODN 2006 to induce IL8 secretion. As expected, we found a marked reduction in IL8 production in the presence of chloroquine (Fig. 7) , thus supporting the role of TLR9 in activation of cervical epithelium by DNA.
DISCUSSION
The mucosal surface of the genitourinary tract provides the first line of defense against sexually transmitted pathogens, and the expression of innate immune receptors at this site dictates the ability of epithelial cells to respond to specific microbial ligands. Although considerable effort has been aimed at understanding TLR responses in professional immune cells, the role of various TLR-related molecules at mucosal surfaces remains poorly understood. In the case of TLR3 and TLR9, the expression and function has been most extensively studied in antigen-presenting cells, such as dendritic cells. The expression of TLR3 and TLR9 has been reported in a variety of mucosal epithelial cell lines of gastric and respiratory origin [35] [36] [37] [38] , although a true role for these receptors in host-pathogen interactions at the mucosal surface remains to be proven. In addition, there have been a number of recent reports examining TLR3 and TLR9 in human uterine epithelium [39] [40] [41] [42] .
Ours is the first account of the expression and function of TLR3 and TLR9 in cervical epithelium. We found that endocervical, ectocervical, and vaginal epithelial cells express messenger RNA for TLR3 and TLR9, and that protein expression is almost exclusively intracellular. Protein function was established using synthetic ligands specific for TLR3 and TLR9. It should be noted that TLR3-independent signaling by double-stranded RNA can occur via the dsRNA-dependent protein kinase (PKR) [43, 44] and the retinoic acid inducible gene 1 (RIG1) [45, 46] . However, published data would suggest that in order for poly[I:C] to activate these intracellular receptors, it must be delivered intracellularly using lipid transfection agents or electroporation [45, 47] . Because we did not undertake such manipulations with the poly[I:C], we feel that the contribution of these other receptors is likely to be minor, although we cannot say with certainty that they did not contribute to the overall response. Thus, the role of PKR and RIG1 in the mucosal epithelial response to double-stranded RNA and poly[I:C] remains to be seen.
Given that our immortalized cell line stably expresses the HPV E6 and E7 proteins, we felt it was important to verify that the TLR3 and TLR9 expression and signaling were, in fact, not an unanticipated consequence of the immortalization process. For example, the E6 protein has been shown to bind IRF3 and inhibit its transactivation function [48] . Thus, one might anticipate some abnormalities in interferon signaling in cells that overexpress E6. However, the confirmation of our findings in terms of gene expression and function in the primary cervical epithelial cells suggests that TLR3 and TLR9 signaling events are intrinsic to this particular tissue and cell type.
Signaling by nucleic acids has been studied in other in vitro systems, but our data reveal some unique features of signaling in cervical epithelium that are noteworthy, and contrast our 828 system with that which has been described in dendritic cells and other professional immune cells. For example, there have been reports that TLR9-mediated responses in dendritic cells induce type 1 interferons [49, 50] . However, although TLR9 activation induced the secretion of the proinflammatory cytokine IL8, we found that the primary cervical epithelial cells did not upregulate IFNB or CCL5, which could be induced by poly[I:C]. Transcriptional regulation of IL8 is primarily dependent on NFKB [51] , whereas IFNB is dependent on IRF3 [52] and CCL5 is regulated by both [53] . The link between TLR9 signaling and type I IFN production was recently reported to be via IRF7 [54] and IRF8 [55] , which are expressed primarily in lymphoid [56, 57] and myeloid cells [58] , respectively. Thus, this lack of TLR9-dependent activation of the IRF signaling pathway might simply reflect an innate difference in the IRFs available in epithelial cells vs. myeloid cells. In addition, it was recently reported that the differential induction of type I IFNs by the type A vs. type B ODNs might be explained by CpG trafficking, a phenomenon that could be overcome by treating the cells with a cationic lipid to enhance endosomal retention [59] . We have yet to explore the subcellular trafficking of DNA in these cells.
Another unique finding in our model stems from the lack of TLR7/TLR8 activity in cervical epithelium. Although it is difficult to confirm protein expression because of the limited antibodies available for these receptors, the identification of a strong PCR product for TLR7 in End/E6E7 cDNA suggests that at least TLR7 is present in the reproductive tract; for TLR8, the weak signal might represent absent or simply inadequate protein expression. However, we failed to observe cell activation by any of the known ligands for TLR7 or TLR8. One possibility is that the cells are simply unable to internalize or properly traffic the TLR7/TLR8 ligands to the proper subcellular location, thus making them inaccessible to the receptor. Although we have not looked specifically at these ligands, we do know the cells will readily take up fluorescently labeled DNA and double-stranded RNA (data not shown). An alternate explanation would be that, in the absence of sufficient TLR8 expression, both TLR7 and TLR8 activity is blunted. It is also possible that TLR7/TLR8-specific adaptor proteins or transcription factors are absent. The molecular basis of this unresponsiveness remains to be determined. It is noteworthy that the imidazoquinolines imiquimod and resiquimod (R848), which are ligands for TLR7/TLR8, are marketed as antiviral and antitumor agents for genital tract infections with agents such as human papilloma virus and herpes simplex virus. Their antiviral effects in terms of type I interferon production are likely to be indirect, via TLR7/TLR8 activation. These data would further suggest that their effect is not on the infected epithelial cells per se, but more likely on the dendritic cells and other professional immune cells that would be found in the subepithelial space of the lower reproductive tract.
The presence of functional TLR3 and TLR9 at mucosal epithelial surfaces supports a role for these receptors in epithelial cell responses to intracellular pathogens. Many viruses that infect cervical epithelial cells either contain dsRNA or express dsRNA during part of the viral life cycle, which could lead to activation of TLR3. Likewise, TLR9 not only would be expected to encounter immunostimulatory DNA that is released during bacterial infections, but also is likely to play a role during genital epithelial infection with viral pathogens, such as herpes simplex virus, which has been reported to contain methylated CpG motifs [50, 60, 61] . These findings suggest that epithelial cell-derived TLR3 and TLR9 are capable of regulating the proinflammatory cytokine and, in the case of TLR3, the antiviral environment of the lower female reproductive tract. The role that these two receptors would play in vivo during a viral or bacterial infection has yet to be adequately investigated. Two groups have reported that activation of TLR9 or TLR3, but not TLR4, in the mouse vagina protects against genital tract infection with herpes simplex virus [60, 62, 63] , suggesting that local delivery of these nucleic acid preparations is activating a protective antiviral response that could be used to protect against sexually transmitted infections. In addition, there are data to suggest that TLR9 activation can enhance the effectiveness of mucosal immunization with viral protein antigens in the genital tract [64] . Perhaps by harnessing the activity of TLR3 and TLR9, one might be able to design better vaccine candidates to improve mucosal immunity either during natural infection or in response to vaccines.
Finally, the role of TLR3 and TLR9 in maintaining the health of the lower female genital tract in the absence of infection remains unclear, as does their hormonal regulation during various stages of the reproductive cycle. Future studies on the role of TLR3 and TLR9, along with the other epithelialspecific TLRs, will need to address the regulation of these receptors in both health and disease as it applies to women's health issues and sexually transmitted infections.
